219 related articles for article (PubMed ID: 22387807)
1. Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy.
Singer LT; Moore DG; Fulton S; Goodwin J; Turner JJ; Min MO; Parrott AC
Neurotoxicol Teratol; 2012; 34(3):303-10. PubMed ID: 22387807
[TBL] [Abstract][Full Text] [Related]
2. Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.
Singer LT; Moore DG; Min MO; Goodwin J; Turner JJ; Fulton S; Parrott AC
Neurotoxicol Teratol; 2016; 54():22-8. PubMed ID: 26806601
[TBL] [Abstract][Full Text] [Related]
3. One-year outcomes of prenatal exposure to MDMA and other recreational drugs.
Singer LT; Moore DG; Min MO; Goodwin J; Turner JJ; Fulton S; Parrott AC
Pediatrics; 2012 Sep; 130(3):407-13. PubMed ID: 22908109
[TBL] [Abstract][Full Text] [Related]
4. Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK.
Singer LT; Moore DG; Min MO; Goodwin J; Turner JJ; Fulton S; Parrott AC
Hum Psychopharmacol; 2015 Jul; 30(4):290-4. PubMed ID: 26216565
[TBL] [Abstract][Full Text] [Related]
5. MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.
Parrott AC; Moore DG; Turner JJ; Goodwin J; Min MO; Singer LT
Hum Psychopharmacol; 2014 Jan; 29(1):1-7. PubMed ID: 24424703
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.
Turner JJ; Parrott AC; Goodwin J; Moore DG; Fulton S; Min MO; Singer LT
J Psychopharmacol; 2014 Jan; 28(1):55-61. PubMed ID: 24327452
[TBL] [Abstract][Full Text] [Related]
7. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
Salisbury AL; Wisner KL; Pearlstein T; Battle CL; Stroud L; Lester BM
Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
[TBL] [Abstract][Full Text] [Related]
8. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
9. Prenatal exposure to alcohol and 3,4-methylenedioxymethamphetamine (ecstasy) alters adult hippocampal neurogenesis and causes enduring memory deficits.
Canales JJ; Ferrer-Donato A
Dev Neurosci; 2014; 36(1):10-7. PubMed ID: 24457993
[TBL] [Abstract][Full Text] [Related]
10. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Taurah L; Chandler C; Sanders G
Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).
Ho E; Karimi-Tabesh L; Koren G
Neurotoxicol Teratol; 2001; 23(6):561-7. PubMed ID: 11792525
[TBL] [Abstract][Full Text] [Related]
12. Prenatal MDMA exposure delays postnatal development in the rat: a preliminary study.
Heuland E; Germaux MA; Galineau L; Chalon S; Belzung C
Neurotoxicol Teratol; 2010; 32(4):425-31. PubMed ID: 20304047
[TBL] [Abstract][Full Text] [Related]
13. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.
LaGasse LL; Wouldes T; Newman E; Smith LM; Shah RZ; Derauf C; Huestis MA; Arria AM; Della Grotta S; Wilcox T; Lester BM
Neurotoxicol Teratol; 2011; 33(1):166-75. PubMed ID: 20615464
[TBL] [Abstract][Full Text] [Related]
14. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
15. Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior.
Chiriboga CA; Kuhn L; Wasserman GA
Neurotoxicol Teratol; 2007; 29(3):323-30. PubMed ID: 17234383
[TBL] [Abstract][Full Text] [Related]
16. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.
Smith LM; LaGasse LL; Derauf C; Newman E; Shah R; Haning W; Arria A; Huestis M; Strauss A; Della Grotta S; Dansereau LM; Lin H; Lester BM
Neurotoxicol Teratol; 2011; 33(1):176-84. PubMed ID: 21256431
[TBL] [Abstract][Full Text] [Related]
17. Infant Behaviors, Prenatal Cocaine Exposure, and Adult Intelligence.
Singer LT; Albert JM; Minnes S; Min MO; Kim JY
JAMA Netw Open; 2024 May; 7(5):e2411905. PubMed ID: 38758554
[TBL] [Abstract][Full Text] [Related]
18. Intermittent prenatal MDMA exposure alters physiological but not mood related parameters in adult rat offspring.
Adori C; Zelena D; Tímár J; Gyarmati Z; Domokos A; Sobor M; Fürst Z; Makara G; Bagdy G
Behav Brain Res; 2010 Jan; 206(2):299-309. PubMed ID: 19782105
[TBL] [Abstract][Full Text] [Related]
19. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.
Moore DG; Turner JD; Parrott AC; Goodwin JE; Fulton SE; Min MO; Fox HC; Braddick FM; Axelsson EL; Lynch S; Ribeiro H; Frostick CJ; Singer LT
J Psychopharmacol; 2010 Sep; 24(9):1403-10. PubMed ID: 19939863
[TBL] [Abstract][Full Text] [Related]
20. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
